Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luu Q. Pham"'
Autor:
Robert Stuver, Steven M. Horwitz, Ranjana H. Advani, Julie M. Vose, Hun Ju Lee, Neha Mehta‐Shah, Jasmine M. Zain, Bradley Haverkos, Mary Jo Lechowicz, Alison J. Moskowitz, Luu Q. Pham, Elizabeth Leyden, Stephen M. Ansell, Matthew A. Lunning
Publikováno v:
British Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b05c0f9741a82a5fe748bb8f16babf
https://doi.org/10.1111/bjh.18885
https://doi.org/10.1111/bjh.18885
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics
Autor:
Kristopher Attwood, Luu Q. Pham, David Peace, Suchitra Sundaram, Sarah Lee, L. Jeffrey Medeiros, Ranjana H. Advani, Brian T. Hess, Daniel J. Landsburg, Adam J. Olszewski, Emma Rabinovich, Stefan K. Barta, Timothy F. Burns, Anshu Giri, Adrienne Groman, Pallawi Torka, Shaoying Li, Joanna C. Zurko, Shalin Kothari, David A. Bond, Madelyn Burkart, Francisco J. Hernandez-Ilizaliturri, Brian T. Hill, Amitkumar Mehta, Emily C. Ayers, Reem Karmali, Jonathon B. Cohen, Julie M. Vose, Michael C. Churnetski, Kami J. Maddocks, Frederick Lansigan, Yang Liu
There is a paucity of data regarding outcomes and response to standard therapy in patients with limited-stage (LS) agressive B-cell lymphoma (LS-ABCL) who harbor MYC rearrangement (MYC-R) with or without BCL2 and/or BCL6 rearrangements. We conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a553c20a5216f21ccba4333bef036966
https://europepmc.org/articles/PMC6988401/
https://europepmc.org/articles/PMC6988401/
Autor:
Adam J. Olszewski, Francisco J. Hernandez-Ilizaliturri, David Peace, Anshu Giri, Brian T. Hill, Daniel J. Landsburg, Joanna C. Zurko, Shalin Kothari, Julie M. Vose, Kris Attwood, Luu Q. Pham, Michael C. Churnetski, Adrienne Groman, L. Jeffrey Medeiros, Ranjana H. Advani, Frederick Lansigan, Madelyn Burkart, Kami J. Maddocks, Sarah S Lee, Emma Rabinovich, Timothy F. Burns, David A. Bond, Reem Karmali, Yang Liu, Brian T. Hess, Pallawi Torka, Emily C. Ayers, Jonathon B. Cohen, Amitkumar Mehta, Shaoying Li, Stefan K. Barta
Publikováno v:
Blood. 132:451-451
Introduction: Patients (pts) with limited stage (LS) aggressive large B-cell lymphoma (ALBCL) comprise 30-40% of ALBCLs and are usually treated with R-CHOP with or without consolidative involved field radiation therapy (IFRT). In pts with ALBCL, cyto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad2f3cbd7e7ff0d12d4e5edb705afe47
https://doi.org/10.1182/blood-2018-99-111530
https://doi.org/10.1182/blood-2018-99-111530
Autor:
Luu Q. Pham, Matthew A. Lunning, Neha Mehta-Shah, Julie M. Vose, Stephen M. Ansell, Elizabeth Lyden, Mary Jo Lechowicz, Alison J. Moskowitz, Ranjana H. Advani, Steven M. Horwitz, Jasmine Zain, Hun Ju Lee, Bradley M. Haverkos, Peggy Heires
Publikováno v:
Blood. 132:2899-2899
Introduction: Lenalidomide (len) is an immunomodulatory agent with single agent activity in relapsed and refractory peripheral T-cell lymphoma (PTCL). CHOEP (cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone) is a common initial r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05adb4056cf20d0a5c99cf552e3003ca
https://doi.org/10.1182/blood-2018-99-114110
https://doi.org/10.1182/blood-2018-99-114110